Senores Pharmaceuticals consolidated net profit rises 83.88% in the June 2025 quarter
Net profit of Senores Pharmaceuticals rose 83.88% to Rs 19.73 crore in the quarter ended June 2025 as against Rs 10.73 crore during the previous quarter ended June 2024. Sales rose 63.90% to Rs 130.30 crore in the quarter ended June 2025 as against Rs 79.50 crore during the previous quarter ended June 2024.
| Particulars | Quarter Ended | ||
| Jun. 2025 | Jun. 2024 | % Var. | |
| Sales | 130.30 | 79.50 | 64 |
| OPM % | 26.22 | 26.82 | - |
| PBDT | 32.48 | 16.98 | 91 |
| PBT | 26.49 | 13.46 | 97 |
| NP | 19.73 | 10.73 | 84 |